Gesellschaft für Zelltherapie

Gesellschaft für Zelltherapie (GZ) is a German biotechnology company and healthcare provider specializing in the development and application of autologous cell therapies. The company focuses on personalized cancer immunotherapy, particularly the production of dendritic cell vaccines designed to stimulate the patient's immune system against tumor-specific antigens. Operating under strict GMP standards, GZ provides specialized laboratory services and therapeutic products for various solid tumors, including melanoma and renal cell carcinoma. The company bridges the gap between clinical research and patient care by offering individualized treatment options in collaboration with specialized clinics.